Latest Curie Capital News
Apr 12, 2023
Sirius Medical BV reported successfully closing a $13 million series B round to develop its tumor localization technology. This round was led by Holland Capital Management BV, with support from existing investor BOM Capital BV – through their vehicle, Brabant Ventures – along with Curie Capital BV and Team Holmium BV, plus major investment from Sirius Medical’s management and team. Norgine Ventures Management Ltd., joined as a new investor in this round. “This new funding means we can support further commercial roll-out of our flagship product, Pintuition,” Bram Schermers, CEO and chief technology officer at Sirius Medical, told BioWorld.
Curie Capital Investments
Curie Capital has made 7 investments. Their latest investment was in Sirius Medical as part of their Series B on March 3, 2023.
Curie Capital Investments Activity
Seed VC - II
Series A - II
Curie Capital Team
1 Team Member
Curie Capital has 1 team member, including current Managing Partner, Mariette van der Velden-Roesink.